
New Concepts in Pathology and Treatment of Autoimmune Disorders
Springer (Publisher)
Published on 3. October 2013
Book
Paperback/Softback
XIII, 139 pages
978-3-662-04452-0 (ISBN)
Description
Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.
More details
Series
Edition
Softcover reprint of the original 1st ed. 2001
Language
English
Place of publication
Berlin
Germany
Publishing group
Springer Berlin
Target group
Professional and scholarly
Research
Illustrations
9 s/w Abbildungen, 6 farbige Abbildungen
XIII, 139 p. 15 illus., 6 illus. in color.
Dimensions
Height: 210 mm
Width: 148 mm
Thickness: 9 mm
Weight
212 gr
ISBN-13
978-3-662-04452-0 (9783662044520)
DOI
10.1007/978-3-662-04450-6
Schweitzer Classification
Other editions
Additional editions

C. Pozzilli | P. Pozzilli | J.-F. Kapp
New Concepts in Pathology and Treatment of Autoimmune Disorders
E-Book
06/2013
1st Edition
Springer
€96.29
Available for download

C. Pozzilli | P. Pozzilli | J.-F. Kapp
New Concepts in Pathology and Treatment of Autoimmune Disorders
Book
05/2001
Springer
€106.99
Shipment within 7-9 days
Content
1 Microarray Technology in the Pathogenesis and Management of Autoimmune Disorders.- 2 Multiple Sclerosis Perspective.- 3 Type 1 Diabetes and Multiple Sclerosis: Similarities and Dissimilarities.- 4 Immunotherapeutic Strategies for Multiple Sclerosis.- 5 Specific Immunotherapy of Multiple Sclerosis by Altered Peptide Ligands - Risk or Benefit?.- 6 Mucosal Immunity - A Key to Tolerance.- 7 New Strategies in Clinical Islet Cell Transplantation.- 8 Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease.- Previous Volumes Published in this Series.